what is microdosing with glp 1 GLP-1 GLP-1 Microdosing Chart: Tirzepatide and

Description

While adequate fluid intake is essential, drinking large volumes with meals can worsen fullness and nausea

it comes in the same dose strengths as the original single-use injector pen

Key pharmacological effects include: Glucose-dependent insulin secretion Enhanced pancreatic beta-cell insulin release only when blood glucose is elevated, reducing hypoglycemia risk Suppression of glucagon secretion Decreased hepatic glucose production from pancreatic alpha cells Delayed gastric emptying Slowed movement of food from the stomach to the small intestine Central appetite regulation Reduced hunger and increased satiety through hypothalamic pathways The delayed gastric emptying effect is particularly significant and represents both a therapeutic mechanism and a potential source of adverse effects

These results are important from a clinical perspective as a reduction in food intake accompanied by weight loss is a desirable outcome in an obese patient

Food and Drug Administration to approve them for treating obesity as long as theres an accompanying cardiovascular issue (in addition to the original type 2 diabetes-related approvals)